Interactions of halichondrin B and eribulin with tubulin.
about
Phylogeny drives large scale patterns in Australian marine bioactivity and provides a new chemical ecology rationale for future biodiscoveryA novel natural phenyl alkene with cytotoxic activityNatural products as sources of new drugs over the 30 years from 1981 to 2010Tumour biology, metastatic sites and taxanes sensitivity as determinants of eribulin mesylate efficacy in breast cancer: results from the ERIBEX retrospective, international, multicenter study.The design, synthesis and biological evaluation of conformationally restricted 4-substituted-2,6-dimethylfuro[2,3-d]pyrimidines as multi-targeted receptor tyrosine kinase and microtubule inhibitors as potential antitumor agents.Evading Pgp activity in drug-resistant cancer cells: a structural and functional study of antitubulin furan metotica compounds.Complementary isonitrile-based multicomponent reactions for the synthesis of diversified cytotoxic hemiasterlin analoguesEribulin targets a ch-TOG-dependent directed migration of cancer cellsEribulin mesylate: mechanism of action of a unique microtubule-targeting agent.Eribulin: a novel cytotoxic chemotherapy agent.Molecular simulations of drug-receptor complexes in anticancer research.Cytotoxicity and glycan-binding properties of an 18 kDa lectin isolated from the marine sponge Halichondria okadai.Clinical efficacy of eribulin mesylate for the treatment of metastatic soft tissue sarcoma.HMBA is a putative HSP70 activator stimulating HEXIM1 expression that is down-regulated by estrogen.Eribulin alone or in combination with the PLK1 inhibitor BI 6727 triggers intrinsic apoptosis in Ewing sarcoma cell lines.Managing sarcoma: where have we come from and where are we going?Effects of eribulin, vincristine, paclitaxel and ixabepilone on fast axonal transport and kinesin-1 driven microtubule gliding: implications for chemotherapy-induced peripheral neuropathy.Antineoplastic agents. 592. Highly effective cancer cell growth inhibitory structural modifications of dolastatin 10.[Search for natural substances with therapeutic activity: George R. Pettit].
P2860
Q28536739-8715259E-F588-423D-9CA5-C3C62F0DDB1BQ28820748-11466C54-44F8-4CC9-A74F-9F5D76506A87Q29616640-79C8A030-7685-422B-867B-3973E2E08074Q33426567-5DE17018-C28A-44E8-9499-03395FE92E89Q35539229-0E48245E-C0B0-4B6F-9946-26CB2F5E8087Q35951551-4A78C2E3-F82E-402E-A4CB-9105E1146A8EQ36389900-C1C5F4B3-6CBB-4E6D-B288-0A4B4D1B9FF7Q36561555-3E6B3117-6946-43F0-A9B3-66834C08E8EBQ36742259-C22A1315-7192-473A-B217-F88175DE9FC0Q38012442-BCE7BF78-5FC5-4593-844E-0DD9B0FFE4E9Q38054133-F5F9193F-3846-4718-9046-BF1E5D14998FQ38323687-E3C0C45E-4D13-451B-8F21-B0050D52AC17Q38688042-7B465FF4-F54C-4953-961A-7B67AB23907CQ38715966-8B5E44C0-415B-4DF8-AF81-A5779918049EQ41592750-4B491981-E156-4B66-A0B7-558D1B555F67Q41988197-655A34C8-B39C-479F-9D92-6DBAA6216BC3Q42112858-3E887272-8698-4F7F-A118-5165194A5F54Q42761153-376DFEFE-86E6-49E4-93E4-C1538EBF8522Q52335669-59415AAE-F567-4558-A81A-28A2F4268B26
P2860
Interactions of halichondrin B and eribulin with tubulin.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Interactions of halichondrin B and eribulin with tubulin.
@ast
Interactions of halichondrin B and eribulin with tubulin.
@en
type
label
Interactions of halichondrin B and eribulin with tubulin.
@ast
Interactions of halichondrin B and eribulin with tubulin.
@en
prefLabel
Interactions of halichondrin B and eribulin with tubulin.
@ast
Interactions of halichondrin B and eribulin with tubulin.
@en
P2093
P2860
P356
P1476
Interactions of halichondrin B and eribulin with tubulin.
@en
P2093
Amos B Smith
Ernest Hamel
George R Pettit
James C Burnett
Murray H G Munro
Onur Atasoylu
Rick Gussio
Tam Luong Nguyen
P2860
P304
P356
10.1021/CI200077T
P577
2011-05-13T00:00:00Z